PDB Short entry for 2KWI HEADER TRANSPORT PROTEIN, PROTEIN BINDING 12-APR-10 2KWI TITLE RALB-RLIP76 (RALBP1) COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAS-RELATED PROTEIN RAL-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 8-185; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RALA-BINDING PROTEIN 1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 393-446; COMPND 11 SYNONYM: RALBP1, RAL-INTERACTING PROTEIN 1, 76 KDA RAL-INTERACTING COMPND 12 PROTEIN, DINITROPHENYL S-GLUTATHIONE ATPASE, DNP-SG ATPASE; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RALB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET16B; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: RALBP1, RLIP1, RLIP76; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_VECTOR: PGEX2T KEYWDS TRANSPORT PROTEIN, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 51 AUTHOR R.B.FENWICK,L.J.CAMPBELL,K.RAJASEKAR,S.PRASANNAN,D.NIETLISPACH, AUTHOR 2 J.CAMONIS,D.OWEN,H.R.MOTT REVDAT 2 06-OCT-21 2KWI 1 REMARK SEQADV REVDAT 1 01-SEP-10 2KWI 0 JRNL AUTH R.B.FENWICK,L.J.CAMPBELL,K.RAJASEKAR,S.PRASANNAN, JRNL AUTH 2 D.NIETLISPACH,J.CAMONIS,D.OWEN,H.R.MOTT JRNL TITL THE RALB-RLIP76 COMPLEX REVEALS A NOVEL MODE OF RAL-EFFECTOR JRNL TITL 2 INTERACTION JRNL REF STRUCTURE V. 18 985 2010 JRNL REFN ISSN 0969-2126 JRNL PMID 20696399 JRNL DOI 10.1016/J.STR.2010.05.013 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AZARA, CNS REMARK 3 AUTHORS : BOUCHER (AZARA), BRUNGER, ADAMS, CLORE, GROS, REMARK 3 NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KWI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000101660. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 0.15 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 50 MM SODIUM PHOSPHATE-1, 100 MM REMARK 210 POTASSIUM CHLORIDE-2, 1 MM REMARK 210 MAGNESIUM CHLORIDE-3, 0.05 % REMARK 210 SODIUM AZIDE-4, 0.8 MM [U-99% REMARK 210 13C; U-99% 15N] RALB-5, 0.8 MM REMARK 210 RLIP76-6, 90% H2O/10% D2O; 50 MM REMARK 210 SODIUM PHOSPHATE-7, 100 MM REMARK 210 POTASSIUM CHLORIDE-8, 1 MM REMARK 210 MAGNESIUM CHLORIDE-9, 0.05 % REMARK 210 SODIUM AZIDE-10, 0.8 MM [U-99% REMARK 210 15N] RALB-11, 0.8 MM RLIP76-12, REMARK 210 90% H2O/10% D2O; 50 MM SODIUM REMARK 210 PHOSPHATE-13, 100 MM POTASSIUM REMARK 210 CHLORIDE-14, 1 MM MAGNESIUM REMARK 210 CHLORIDE-15, 0.05 % SODIUM AZIDE- REMARK 210 16, 0.8 MM [U-99% 13C; U-99% 15N] REMARK 210 RLIP76-17, 0.8 MM RALB-18, 90% REMARK 210 H2O/10% D2O; 50 MM SODIUM REMARK 210 PHOSPHATE-19, 100 MM POTASSIUM REMARK 210 CHLORIDE-20, 1 MM MAGNESIUM REMARK 210 CHLORIDE-21, 0.05 % SODIUM AZIDE- REMARK 210 22, 0.8 MM [U-99% 15N] RLIP76-23, REMARK 210 0.8 MM RALB-24, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HNCO; 3D HN(CO)CA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D H(CCO)NH; 2D 1H- REMARK 210 13C HSQC; 3D HCCH-TOCSY; 3D 1H- REMARK 210 15N NOESY; 3D 1H-13C NOESY; 3D REMARK 210 HBHA(CO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANALYSIS, ARIA, CNS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 51 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ2 LYS A 27 OD1 ASP A 68 1.51 REMARK 500 HZ1 LYS A 115 OE2 GLU A 118 1.58 REMARK 500 HZ3 LYS B 442 OE2 GLU B 445 1.59 REMARK 500 HZ1 LYS A 54 OE1 GLU A 61 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 25 -51.75 71.23 REMARK 500 1 PRO A 45 -104.47 -27.67 REMARK 500 1 LEU A 72 -58.26 -142.14 REMARK 500 1 GLU A 73 -53.96 176.08 REMARK 500 1 ASP A 74 -72.03 -57.11 REMARK 500 1 SER A 85 37.97 -91.37 REMARK 500 1 GLU A 87 -74.48 -65.22 REMARK 500 1 ALA A 116 -31.43 -151.26 REMARK 500 1 ASP A 119 -82.76 -66.18 REMARK 500 1 LYS A 129 42.15 77.09 REMARK 500 1 GLU A 133 -77.66 62.20 REMARK 500 1 ARG A 162 66.43 61.44 REMARK 500 1 SER A 182 173.91 64.79 REMARK 500 1 GLU A 183 -73.62 -107.73 REMARK 500 1 SER B 392 28.22 -157.47 REMARK 500 2 GLN A 9 -69.31 -161.77 REMARK 500 2 SER A 10 15.10 -154.74 REMARK 500 2 SER A 11 92.62 67.07 REMARK 500 2 VAL A 25 -51.95 70.16 REMARK 500 2 TYR A 36 -105.26 -96.31 REMARK 500 2 ASP A 37 -30.86 177.79 REMARK 500 2 TYR A 43 100.73 -166.95 REMARK 500 2 ASP A 58 81.27 36.82 REMARK 500 2 ARG A 79 -65.43 -92.34 REMARK 500 2 PHE A 83 -159.49 -79.88 REMARK 500 2 ARG A 84 -69.45 69.38 REMARK 500 2 GLU A 87 -71.83 -105.27 REMARK 500 2 LYS A 115 -87.73 -121.55 REMARK 500 2 ALA A 116 -74.47 66.15 REMARK 500 2 GLU A 117 42.31 -85.35 REMARK 500 2 ASP A 119 -48.51 75.23 REMARK 500 2 LYS A 129 63.83 62.98 REMARK 500 2 GLU A 133 -67.48 67.55 REMARK 500 2 VAL A 152 -168.50 -126.08 REMARK 500 2 SER A 182 167.07 70.44 REMARK 500 2 GLU B 393 -71.59 -74.29 REMARK 500 3 GLN A 9 -153.10 -141.88 REMARK 500 3 LEU A 12 43.63 -85.24 REMARK 500 3 VAL A 25 -52.13 68.31 REMARK 500 3 ASP A 42 101.79 -160.47 REMARK 500 3 PRO A 45 96.63 -52.45 REMARK 500 3 THR A 46 65.14 -153.96 REMARK 500 3 ASP A 58 75.50 46.58 REMARK 500 3 ASP A 74 -73.97 -74.60 REMARK 500 3 ARG A 79 -63.87 -91.61 REMARK 500 3 GLU A 87 -75.13 -155.96 REMARK 500 3 LYS A 115 -102.03 -127.82 REMARK 500 3 ALA A 116 -42.77 68.24 REMARK 500 3 GLU A 117 34.60 -79.21 REMARK 500 3 GLU A 118 -96.23 -97.98 REMARK 500 REMARK 500 THIS ENTRY HAS 839 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 36 ASP A 37 20 -149.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15525 RELATED DB: BMRB REMARK 900 RELATED ID: 15803 RELATED DB: BMRB REMARK 900 RELATED ID: 2KWH RELATED DB: PDB DBREF 2KWI A 8 185 UNP P11234 RALB_HUMAN 8 185 DBREF 2KWI B 393 446 UNP Q15311 RBP1_HUMAN 393 446 SEQADV 2KWI LEU A 72 UNP P11234 GLN 72 ENGINEERED MUTATION SEQADV 2KWI GLY B 391 UNP Q15311 EXPRESSION TAG SEQADV 2KWI SER B 392 UNP Q15311 EXPRESSION TAG SEQADV 2KWI SER B 411 UNP Q15311 CYS 411 ENGINEERED MUTATION SEQRES 1 A 178 GLY GLN SER SER LEU ALA LEU HIS LYS VAL ILE MET VAL SEQRES 2 A 178 GLY SER GLY GLY VAL GLY LYS SER ALA LEU THR LEU GLN SEQRES 3 A 178 PHE MET TYR ASP GLU PHE VAL GLU ASP TYR GLU PRO THR SEQRES 4 A 178 LYS ALA ASP SER TYR ARG LYS LYS VAL VAL LEU ASP GLY SEQRES 5 A 178 GLU GLU VAL GLN ILE ASP ILE LEU ASP THR ALA GLY LEU SEQRES 6 A 178 GLU ASP TYR ALA ALA ILE ARG ASP ASN TYR PHE ARG SER SEQRES 7 A 178 GLY GLU GLY PHE LEU LEU VAL PHE SER ILE THR GLU HIS SEQRES 8 A 178 GLU SER PHE THR ALA THR ALA GLU PHE ARG GLU GLN ILE SEQRES 9 A 178 LEU ARG VAL LYS ALA GLU GLU ASP LYS ILE PRO LEU LEU SEQRES 10 A 178 VAL VAL GLY ASN LYS SER ASP LEU GLU GLU ARG ARG GLN SEQRES 11 A 178 VAL PRO VAL GLU GLU ALA ARG SER LYS ALA GLU GLU TRP SEQRES 12 A 178 GLY VAL GLN TYR VAL GLU THR SER ALA LYS THR ARG ALA SEQRES 13 A 178 ASN VAL ASP LYS VAL PHE PHE ASP LEU MET ARG GLU ILE SEQRES 14 A 178 ARG THR LYS LYS MET SER GLU ASN LYS SEQRES 1 B 56 GLY SER GLU THR GLN ALA GLY ILE LYS GLU GLU ILE ARG SEQRES 2 B 56 ARG GLN GLU PHE LEU LEU ASN SER LEU HIS ARG ASP LEU SEQRES 3 B 56 GLN GLY GLY ILE LYS ASP LEU SER LYS GLU GLU ARG LEU SEQRES 4 B 56 TRP GLU VAL GLN ARG ILE LEU THR ALA LEU LYS ARG LYS SEQRES 5 B 56 LEU ARG GLU ALA HET GNP A 500 45 HET MG A 501 1 HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION FORMUL 3 GNP C10 H17 N6 O13 P3 FORMUL 4 MG MG 2+ FORMUL 5 HOH *2(H2 O) HELIX 1 1 SER A 28 ASP A 37 1 10 HELIX 2 2 TYR A 75 ASP A 80 1 6 HELIX 3 3 GLU A 97 LYS A 115 1 19 HELIX 4 4 PRO A 139 GLY A 151 1 13 HELIX 5 5 ASN A 164 SER A 182 1 19 HELIX 6 6 SER B 392 GLY B 418 1 27 HELIX 7 7 ASP B 422 ALA B 446 1 25 SHEET 1 A 6 ARG A 52 LEU A 57 0 SHEET 2 A 6 GLU A 60 ASP A 68 -1 O VAL A 62 N VAL A 55 SHEET 3 A 6 LEU A 14 VAL A 20 1 N HIS A 15 O ASP A 65 SHEET 4 A 6 GLY A 88 SER A 94 1 O LEU A 90 N ILE A 18 SHEET 5 A 6 LEU A 123 ASN A 128 1 O VAL A 126 N LEU A 91 SHEET 6 A 6 TYR A 154 GLU A 156 1 O VAL A 155 N GLY A 127 SITE 1 AC1 16 GLY A 24 GLY A 26 SER A 28 ALA A 29 SITE 2 AC1 16 PHE A 39 GLU A 44 PRO A 45 THR A 46 SITE 3 AC1 16 ASN A 128 LYS A 129 ASP A 131 SER A 158 SITE 4 AC1 16 ALA A 159 LYS A 160 MG A 501 HOH A 503 SITE 1 AC2 6 SER A 28 THR A 46 ASP A 68 GNP A 500 SITE 2 AC2 6 HOH A 502 HOH A 503 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000